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ApoptosisMFG-E8 (also known as lactadherin), which is a secreted glycoprotein from a variety of cell types, possesses
two EGF domains and tandem C domains with sequence homology to that of blood coagulation proteins
factor V and factor VIII. MFG-E8 binds to phosphatidylserine (PS) in membranes with high afﬁnity.
We have recently shown that the C2 domain of MFG-E8 bears more speciﬁcity toward PS when compared
with phosphatidylcholine (PC), another phospholipid thought to be involved in the immune function of
phagocytes. In our current study, we have determined the solution structure of the C2 domain by nuclear
magnetic resonance (NMR) spectroscopy, and characterized the molecular basis of binding between the C2
domain and PS by 31P-NMR spectroscopy. Furthermore, we also veriﬁed that that positively charged and
aromatic residues clustered in loops 1–3 of the C2 domain play key roles in recognizing PS in apoptotic cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mouse milk fat globule-EGF factor 8 protein (MFG-E8), also known
as lactadherin, is a soluble and heavy glycoprotein, which is expressed
and secreted by various cells and tissues, includingmammary epithelial
cells, stimulated macrophages, stimulated endothelial cells, brain,
spleen, lymph nodes, and mammary glands of human, mice, pig, and
cow [1–4]. It consists of two repeated EGF-like domains on the
N-terminal side, followed by two C domains (C1 and C2 domains), and
has two alternative splice variants based on the presence or absence of
a proline/threonine-rich domain [2]. The RGD (Arg-Gly-Asp) motif in
the second EGF-like domain is recognized by some members of the
integrin family of receptors, including αvβ3 and αvβ5, which facilitate
cell–cell adhesion [2,5,6]. The C2domain ofMFG-E8 is the primary recog-
nition site for PS-exposed membranes [6,7].
Macrophage clearance of apoptotic cells is a key process for
preventing inﬂammation and the autoimmune response against
intracellular antigens often released by dying cells. As cells undergo
apoptosis, PS becomes exposed and is recognized by phagocytes,
such as macrophages and dendritic cells as an ‘eat me’ signal,
resulting in the engulfment of apoptotic cells [8]. MFG-E8 secretednces, Nanyang Technological
apore. Tel.: +65 6316 2846;
rights reserved.from activated macrophages plays an important role as a linker
between the PS-exposed apoptotic cells through its C2 domain and
the macrophage through its RGD motif [2]. Indeed, PS-masking by a
point mutation in the RGD motif induces apoptotic cell accumulation
in mice [9]. Moreover, in MFG-E8-deﬁcent mice, apoptotic lympho-
cytes are not efﬁciently engulfed by tangible body macrophages [3],
with MFG-E8 deﬁciency leading to autoimmune diseases, such as
splenomegaly, glomerulonephritis, and atherosclerosis in mice [3,10].
The C2 domain in MFG-E8 shares homology with the membrane-
binding C2 domains of coagulation factors V and VIII [11,12], but is
not related to the Ca2+-binding C2 domains of synaptotagmin, phospho-
lipase A2 or protein kinase C [13]. The common feature of membrane-
binding C2 domains is an eight-stranded antiparallel β sandwich scaffold
along with several irregular loops [14,15]. These loops exhibit consider-
able variability and may have potential membrane-binding amino acids
that interact with the membrane and/or the hydrophilic head group of
PS by stereospeciﬁc binding or electrostatic properties. Evidence from
the crystal structures of the C2 domains of factor V, factor VIII and
MFG-E8 suggest that a group of water-exposed hydrophobic residues
and glycine residues protruding from these long loops may mediate
membrane binding by insertion into the membrane [16,17]. In addition,
computational docking studies provide hypothetical PS binding sites,
but the sites differ between MFG-E8 and factor V or VIII [13].
In agreement with previous studies, we have recently shown that
the C2 domain of MFG-E8 bears more speciﬁcity toward PS when
compared with phosphatidylcholine (PC), another phospholipid
thought to be involved in the immune function of phagocytes [2,18].
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lar basis of the speciﬁc interaction between the C2 domain and PS. To
this end, in our current study, we expressed and puriﬁed C2 domain
of MFG-E8 to determine its three-dimensional structure by nuclear
magnetic resonance (NMR) spectroscopy. We also performed muta-
genesis studies to determine the key residues involved in the interac-
tion with PS by analyzing the binding characteristics of mutant
protein with phospholipids by 31P-NMR spectroscopy. Furthermore,
we conﬁrmed that key residues, which were identiﬁed from the
NMR studies, play important roles in the PS-recognition in apoptotic
cells in response to death stimuli.
2. Materials and methods
2.1. Materials
15N-NH4Cl and 13C-Glucose were purchased from Cambridge Isotope
Laboratories, Inc. (Andover, MA, USA). Etoposide was purchased from
Calbiochem (La Jolla, CA).
2.2. Construction of expression plasmids
The C2 domain (His306-Cys463) of mouse MFG-E8 (GenBank
Accession No. AK171143) was cloned into a pET29b vector, as we de-
scribed in detail elsewhere [18]. The enhanced green ﬂuorescent pro-
tein (EGFP) cDNA (GenBank Accession No. U55763) was cloned into
the BamHI and EcoRI sites of pGEX-4T-1 (Pharmacia Biotech, Uppsala,
Sweden) to produce a new pGEX-EGFP plasmid. The DNA fragment
corresponding to the C2 domain of MFG-E8 was then subcloned into
the EcoRI and XhoI sites of the pGEX-EGFP. Mutations in the C2
domain (K24N, K45N, R79Q and R146Q, K24N/K45N, W26A, F81A and
W26A/F81A) were generated using complementary oligonucleotides
with the desired mutation via standard site-directed mutagenesis. All
constructs were conﬁrmed by DNA sequencing.
2.3. Preparation of recombinant proteins
Recombinant mouse MFG-E8 C2 domain was expressed and puri-
ﬁed, as we previously described [18]. For NMR study, the isotopicallyTable 1
Structural statistics for NMR structure of MFG-E8 C2 domain.
Unambiguous NOE restraints 2067
Intra-residual (i=j) 455
Sequential (|i–j|=1) 700
Medium range (1b |i–j|b5) 188
Long range (|i–j|≥5) 724
Dihedral angle restrains
All 110
Φ 56
Ψ 54
Hydrogen bond restraints (upper/lower) 99/99
Disulﬁde bond 1
Total number of restraint violations>0.4 0
Total number of dihedral angle violations>5° 0
Average RMSD (Å) to mean for the top 20 structures
Residues 1–158
Backbone atoms 1.5±0.25
All heavy atoms 2.18±0.23
Residues 17–20,59–96,102–104,112–156
Backbone atoms 0.73±0.10
All heavy atoms 1.40±0.14
Residues 14–24,36–156
Backbone atoms 0.92±0.16
All heavy atoms 1.55±0.16
Ramachandran analysis (%)
Residues in most favored regions 59.9%
Residues in additional allowed regions 35.1%
Residues in generously allowed regions 3.7%
Residues in disallowed regions 1.4%labeled MFG-E8 C2 proteins were expressed in Escherichia coli (E. coli)
BL21 (DE3) cells grown in M9 medium containing 15NH4Cl, or 15NH4Cl
plus [U-13C]-glucose and puriﬁed by Ni2+-afﬁnity followed by Sephacryl
S-200. The puriﬁed MFG-E8L C2 was concentrated to 0.8 mM in a buffer
containing 20 mM sodium phosphate (NaPO4), pH 6.5, 20 mM NaCl,
0.01% sodium azide (NaN3) and 10% or 100% D2O). For ﬂuorescence-
activated cell sorting (FACS) analysis, the plasmids were transformed
into E. coli BL21 cells to produce GST-EGFP-C2 domain fusion proteins be-
fore being induced with 1 mM isopropyl-1-thio-β-D-galactopyranoside
(IPTG) for 4 h at 25 °C. Cells were lysed by sonication in a phosphate-
buffered saline (PBS) containing 1 mM phenylmethanesulfonylﬂuoride
(PMSF). The soluble fraction of the lysate was incubated with
glutathione-sepharose beads (Amersham Biosciences, Little Chalfont,
UK) for 1 h at 4 °C. The beads were washed with PBS and the proteins
were eluted from the beads with 10 mM reduced glutathione in
50 mMTris, pH 8.0. The concentration of the puriﬁed proteinwas deter-
mined by Bradford dye assay kit (Bio-Rad Laboratories).
2.4. Nuclear magnetic resonance (NMR) spectroscopy experiments
NMR spectra were acquired on a Bruker Avance 700 MHzNMR spec-
trometer equipped with four RF channels and a 5 mm z-gradient TXI
CryoProbe (Bruker BioSpin) at 298 K. Spectra were processed with
Topspin version 1.3 (Bruker) and analyzed using Sparky (Goddard T. D.
and Kneller D. G., SPARKY3, University of California, San Francisco) and
NMRview [19]. Backbone assignment was made from HNCA, HNCO,
HNCACB, CBCACONH and 3D 15N-HSQC-NOESY [13]. Side-chain assign-
ments were made from 3D HC(C)H-TOCSY, H(CC)(CO)NH, (H)CC(CO)
NH and 13C-HSQC-NOESY. Nuclear Overhauser effects (NOE) distance
constraints were provided by 3D 15N- and 13C-edited NOESY spectra ac-
quired with mixing time of 120 ms and 3D aromatic 13C-HMQC-NOESY
spectra acquired with mixing time of 80 ms. The exchanging amide
protons were monitored by dissolving the lyophilized protein in D2O
and acquiring a series of 15N-HSQC spectra.
2.5. Structural calculation
NMR spatial structures of the MFG-E8 C2 were calculated using
CYANA [20]. NOE distance constraints for the structure calculation
were obtained from 3D 15N- and 13C-edited NOESY and 3D aromatic
13C-HMQC-NOESY spectra. Dihedral angle restraints were calculated
from chemical shifts using Torsion Angle Likelihood Obtained from
Shift and sequence similarity (TALOS) and the overall secondary struc-
ture was predicted from the Chemical Shift Index (CSI) and NOE pattern
[21]. The slowly exchanging amide protons were assigned as hydrogen
bond donors with related hydrogen-acceptor partners on the basis of
the calculated preliminary structure. The standard CYANA simulated
annealing protocol was applied to 100 random structures and the
resulting 20 energy-minimized structures with the lowest target func-
tion energy were selected for further analysis. Structures were analyzed
using the program PROCHECK and visualized by MOLMOL, PyMOL
(www.pymol.org) and Swiss-PdbViewer [21–23]. The chemical shifts
and the NMR-derived restraints and atomic coordinates of the protein
ensemble have been deposited at BioMagResBank (www.bmrb.wisc.
edu) with accession code BMRB 17477 and the Protein Data Bank
(www.pdb.org) with accession code PDB 2L9L, respectively.
2.6. 2D 1H-15N heteronuclear single quantum correlation (HSQC) titration
with 06:0 PS
1,2-Dihexanoyl-sn-glycero-3-phospho-L-serine (06:0 PS) (Avanti
Polar Lipids, Inc.) was dissolved into buffer containing 20 mM
NaPO4, pH 6.5, 50 mM NaCl, 0.01% NaN3, to make stock solution of
3 mM concentration. The 15N labeled protein sample was expressed
and puriﬁed as mentioned above, and concentrated to about 0.2 mM in
the buffer containing 20 mM NaPO4, pH 6.5, 50 mM NaCl, 0.01% NaN3,
Fig. 1. (A) Structure of the MFG-E8 C2 domain conformer with the lowest energy. (B) Structural alignment of mouse MFG-E8 C2 (black) and bovine MFG-E8 C2 (red; PDB code: 3BN6)
domains. (C) Ensemble of the top 20 MFG-E8 C2 domain conformers. Cys1 and Cys156 with disulﬁde bridges are displayed in yellow.
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concentration of 0.12 mM and lipid concentration of 1.2 mM, with
molar ratio of 1:10. 1H-15N HSQC spectra were acquired on a Bruker
Avance 700 MHz NMR spectrometer.
2.7. 31P NMR spectroscopy
Phosphatidylserine (0.25 mM) and the wild type C2 domain and
its mutants (were prepared in a buffer containing 10 mM NaPO4,
pH 6.5, 10 mM NaCl, 10 mM CHAPS, 0.01% NaN3 and 10% D2O. 31P
NMR spectroscopy of PS was determined as we previously described
[18]. The binding constant (Kd) for PS with the C2 domain was deter-
mined by one binding site equation by plotting the chemical shift data
vs. the protein concentration as described [24].
2.8. Molecular docking study
To identify potential binding residues for the head group of PS,
molecular dockings were performed using Gold 4.0 [25]. Coordinates
of PS were taken from its complex with protein kinase C (PDB ID:
1DSY) and employed for docking PS with the mouse C2 domain.
Alignment of different C2 members, factor V C2, factor VIII C2, human,
bovine and mouse MFGE-8 C2 domains (Fig. 3A) suggests that residues
in the spike/loop region are conserved and could participate in mem-
brane binding. Further binding site analysis also revealed potential sites
at which PS docks at these spikes or loops. Gold molecular docking
software was employed to dock PS with protruding loops or spikes of
the C2 domain [25]. A region around 10 Å from these spikes was de-
ﬁned to dock PS using annealing parameters of hydrogen bond and
Van der Waal's interactions at 2.5 and 4.0 Å, respectively, with
docking solutions within 1.5 Å RMSD considered. Electrostaticcalculations were numerically solved from the linear Poisson–
Boltzmann equation with the aid of APBS code associated with
the PyMol software package [26].
2.9. Detection of apoptotic cells using ﬂow cytometer
HeLa cells were maintained in Dulbecco's modiﬁed Eagle's medium
(DMEM) containing 10% fetal calf serum and 1% penicillin/streptomycin
in a humidiﬁed 5% CO2 incubator at 37 °C. Cells treated with 100 μM
etoposide (Calbiochem, La Jolla, CA) for 24 h were harvested for detec-
tion of phosphatidylserine on the outer leaﬂet of apoptotic cell mem-
branes. Cells were incubated with 1 μM EGFP-C2 domain wild type or
mutants in buffer containing 50 mM HEPES, pH 7.2, 0.1 M NaCl and
1 mg/L Propidium Iodide (PI) for 20 min at room temperature. For the
control experiment, apoptosis was examined by using Annexin
V-FLUOS staining kit (Roche, Penzberg, Germany). Cell samples were
analyzed by a FACSCalibur ﬂow cytometer (Becton Dickinson, San
Diego, CA) equipped with CellQuest software. Fluorescein emission
intensity for EGFP-C2 domain and annexin V was evaluated via the
530±30 nm band pass ﬁlter.
3. Results
3.1. The NMR structure of MFG-E8 C2 domain
The structural statistics for the NMR structure determination of
the C2 domain of MFG-E8 are shown in Table 1. The input data for
the NMR structure calculation included 2067 NOE distance restraints,
distance restraints for 99 hydrogen bonds, and 110 backbone (φ, ψ)
dihedral angle restraints. The 13C chemical shifts predicted a disulﬁde
bond forming between the residues Cys1 and Cys156 [27], consistent
Fig. 2. 1H-15N HSQC of MFG-E8 C2 domain binding with 06:0 PS. (A) Overlay of 1:10 molar ratio spectrum (blue) with free protein spectrum (red). (B and C) Zoom in on selected
residues having signiﬁcant changes.
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main of bovine and blood coagulation protein factors V and VIII; hence,
the structure was calculated with the disulﬁde bond restraints between
the two residues. Interestingly, these two cysteine residues are conserved
in all of the homologous C2 domain sequences and located very close to
the N- and C-terminal extremities of these proteins. In fact, most of
these protein sequences did not contain any additional cysteine residues.
The two cysteine residues might play an essential role in the stabilization
of the protein structure and/ormaintenance of a functional conformation.
The root-mean-square deviation (RMSD) values relative to the mean co-
ordinate of 20 representative conformers (Table 1) were determined to
be 0.73 Å for the backbone atoms and 1.40 Å for heavy atom for residues
in well-deﬁned regions (17–20,59–96,102–104,112–156). The residues
observed in disallowed regions (1.4%) belonged to the loop regions. Like
other C2 domain structures, the mouse MFG-E8 C2 domain has four
small β strands and a sandwich-like core containing two β-sheets,
which are composed of ﬁve and three major anti-parallel β-strands, re-
spectively, that face each other (Fig. 1A). The alignment of the C2 domain
amino acid sequences fromMFG-E8 of mouse and bovine shows that C2
domain sequences are highly conserved [12]. The RMSD for the
α-carbon atoms between the lowest energy NMR structure of the
mouse MFG-E8 C2 domain and the crystal structure of the bovine
MFG-E8 C2 domain (PDB ID: 3BN6) was 1.52 Å (Fig. 1B). These differ-
ences betweenNMRandX-ray structuresmainly come from the loops be-
tween β-sheets, for example, residues Thr25-Ala30 and loop between β5
and β6. In our NMR structural determination, the amide resonances ofresidues Thr25-Ala30weremissing in the 2D 1H-15Nheteronuclear single
quantum correlation (HSQC) spectrum, indicating that theymay undergo
fast exchange with the solvent, as they reside in the ﬂexible loop region,
which is consistent with the highest average B-factor value of the Cα
atoms of residues Thr25-Ala30 of bovine MFG-E8 C2 domain (PDB ID:
3BN6) [13]. Our NMR structure suggested possible states of this ﬂexible
region as shown in the ensemble with higher RMSD values (Fig. 1C).
3.2. Molecular interaction study of MFG-E8 C2 domain with 06:0 PS
After comparing different forms and compositions of phospholipids
(data not shown), 1,2-dihexanoyl-sn-glycero-3-phospho-L-serine (06:0
PS) was chosen and its binding with C2 domain was examined by 2D
HSQC. 15N-labelled C2 was titrated with PS until the ﬁnal concentration
to 0.12 mM for protein and 1.2 mM for PS. 1H-15N HSQC spectrum was
acquired as mentioned in the method section, and overlaid onto that of
the free protein (Fig. 2). Overall attenuation of the NMR signals was ob-
served. Only about 40 to 50% of the original intensity was maintained.
This might be due to the line broadening caused by protein binding
with PS micelle. From the analysis of the HSQC overlay, peaks for
Tyr23, Lys24, Trp33, Asn42, Gly44, Lys45, Asn47, Ala48, Trp49, Gly77,
Ala78, Gly82, Gln85, Asn116, Leu117, Asn119, Asn120 and Ser121 were
shifted from the original position, and peaks for Phe31, Gly32, Ile46,
Arg79, Phe81, and Arg150 disappeared after titration (Fig. 3). These
residues showing chemical shift perturbations were mapped on the C2
domain. It was interesting that almost all of these residues are located
Fig. 3. (A) Analysis of HSQC titration results of C2 binding with PS. Disappeared residues were combined into chemical shift perturbation histogram by being treated as having
chemical shift perturbation of 1 ppm. Residues chosen to be mutated were colored red. (B) Mapping of disappeared or shifted residues on MFG-E8 C2 domain structure selected
from our structure ensemble. Red colored residues were disappeared ones; purple colored residues were shifted ones.
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importance of these loops in the binding event.
3.3. Electrostatic interaction is critical for PS binding
Mutations to any of the charged residues (Lys24, Lys45 and
Arg146) would considerably decrease the binding afﬁnity of a phos-
pholipid, presumably due to the loss of the positively charged electro-
static map, which recognizes the negatively charged phosphate and
drives the proper orientation of the PS head into the groove (Fig. 4).
To conﬁrm whether the positively charged residues in C2 domain
were involved in the interaction with an anionic phospholipid, suchas PS, we made several mutants by site-directed mutagenesis and
performed 31P-NMR. As shown in Fig. 4, the stacked spectra illustrate
the PS binding to the C2 wild type or mutants in phosphate buffer.
As we described in our previous report [18], the spectra of the C2 wild
type showed two major peaks, including phosphorous from the buffer
(0 ppm) and free- and bound-state of PS (−1.35 ppm), and one small
peak (−1.06 ppm) that indicated the bound-state of PS. This small
peak was in the slow exchange limit, appearing as a doublet signal
under increasing concentrations of the C2 protein (Fig. 4). Under the
same conditions, the binding afﬁnities of all of the C2 mutants, (K24N,
K45N, R79Q and R146Q) for PS were dramatically reduced (Fig. 4). In
addition, the dissociation constants (Kd) of these mutants for PS
Fig. 4. 31P NMR spectrum of PS with wild type or mutant C2 domain. 31P NMR spectra
of PS was recorded on a Avance 400 MHz NMR spectrometer according to the increas-
ing concentration of C2 wild type or point mutants (K24N, K45N, R79Q, R146Q), as in-
dicated. Stacked plot gives the 31P-NMR spectra of phosphate buffer (0 ppm),
bound-state of PS (−1.06 ppm), and free- (F) and bound- (B) state of PS (−1.35 ppm).
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wild type (Table 2); this indicated reduced binding afﬁnity after muta-
tion of positively charged residues.3.4. Molecular interaction between MFG-E8 C2 domain and
phosphatidylserine
Electrostatic analysis of the C2 protein and the residues that are
conserved across different C2 family members reveal the presence
of polar residues, including Lys24, Thr25, Arg29, Lys45, Gly77,
Asp80, Gln85, Arg146, Arg150, as well as hydrophobic residues,
such as Trp33, Phe31, Phe81, Leu28, and Trp26 anchoring the poten-
tial PS-binding loops (Fig. 5A). Our docking results of the regions of
the predicted PS recognition loops showed that PS could form six
hydrogen bonding contacts with the C2 domain. Mainly, the serine-
carboxyl head group on PS formed weak salt bridge interactions
with Gln77 and Arg146. In addition, the head group of PS is also
engaged in hydrogen bonding with the main chain amide atoms of
Arg79. The PS binding could further be stabilized by the interaction
between the phosphoryl oxygen on PS with the side chain amide
atoms of Lys45 and Phe81 residues, which anchor the tips of loop 2
and loop 3. One of the carbonyl groups on the acyl chains of PS inter-
acts with the side chain amide atoms of Lys45. In addition to these
interactions, the acyl tails of PS were also involved in hydrophobic
interactions with solvent-exposed residues such as Trp26 and Phe81
(loop 1, 3) (Fig. 5B). Electrostatic analysis of the PS–C2 complex
shows that the positively charged residues mainly drive the dockingTable 2
Binding constants (Kd) of the C2 domain wild type and
mutants.
C2 Kd (μM)
Wild type 19±0.07
K24 N 670±30
K45 N 1400±70
R79 Q 1030±50of the serine-carboxyl head group of PS, and that the hydrophobic
interactions between the acyl chains and the solvent exposed aromat-
ic residues stabilized the binding of PS with the C2 domain (Fig. 5C).3.5. C2 domain binds to PS-exposed apoptotic cells
To test the role of the C2 domain in PS-exposed cellular apoptosis,
an EGFP-tagged C2 domain was puriﬁed and then incubated with
HeLa cells, which were induced to undergo apoptosis by treatment
with 100 μM etoposide for 24 h. Since annexin V binds apoptotic
cells by recognizing PS, as a comparison and positive control,
etoposide-treated cells were also incubated with Annexin V and PI,
simultaneously. As shown in Fig. 7, during the 24 h after etoposide
exposure, increasing amounts of PS were exposed, as detected by
annexin V (Fig. 6A; top panel, right lower quadrant). Approximately
55% of cells were positive for annexin V staining, but negative for PI
in apoptosis-inducing conditions. By comparison, 5% of cells were
positive for both annexin V and PI staining. Similarly, the C2 domain
also showed progressive binding to cells with increased exposure
of PS in apoptotic conditions (Fig. 6A; bottom panel, right lower
quadrant). Approximately 3% of cells were found in the right lower
quadrant in the control (non-apoptosis-induced) cells. In contrast,
about 30% of cells were positive for C2 domain staining, but negative
for PI in apoptosis-inducing conditions. Another 12% of cells exposed
to PS with PI staining (Fig. 6A). These ﬁndings suggested that the C2
domain binds to PS-exposed apoptotic cells efﬁciently.
To identify the binding efﬁciency of the C2 domain to PS-exposed
apoptotic cells, cells were incubated with several concentrations of
the C2 domain (0.1–5.0 μM) and etoposide and analyzed by ﬂow
cytometry. The results showed that the binding afﬁnity of the C2 do-
main to the PS-exposed apoptotic cells increased in a concentration-
dependent manner up to 1 μM, plateauing at higher concentrations
(Fig. 6B). Approximately 40% of cells were positive for annexin V
staining and negative for PI in apoptosis-inducing conditions; where-
as approximately 25% of cells were positive for C2 domain staining
and negative for PI. The results showed about 60% of the binding
efﬁciency of C2 domain to PS-exposed cells as compared with that
of annexin V as a control.3.6. Positively charged residues in the C2 domain are involved in the
binding to PS-exposed apoptotic cells
To conﬁrm whether the positively charged residues in the C2
domain were important for the binding between MFG-E8 and PS,
we chose two lysine residues, Lys24 and Lys45, to be mutated into as-
paragine and checked for PS binding using the same incubation times,
concentrations and ﬂow cytometry procedure as described above. In
the non-apoptosis induced cells, more than 90% of cells remained in
the lower left quadrant (representing cells not undergoing apoptosis)
for all experiments. After inducing apoptosis, 56% of apoptotic cells
failed to bind to the C2 wild-type domain. This percentage increased
when cells were incubated with the C2 domain harboring two single
mutations, K24N and K45N, to 65% and 83%, respectively, indicating
that binding of apoptotic cells to the C2 domain was inhibited with
these single point mutations (Fig. 7A,B); this result was in accordance
with its Kd value against PS. In particular, in the case of the K24N/
K45N double mutant, almost none of the cells showed binding to
the C2 domain, with almost 100% of cells gated as M1 (Fig. 7A,B). In
addition, there was a shift in the proportion of PI- and double
mutant-positive cells as compared with cells stained with C2 wild
type (Fig. 7A), indicating a dramatic inhibition in the binding afﬁnity
of the double-mutant C2 domain to apoptotic cells. These results
suggest that the positively charged residues in C2 domain contributed
to the recognition of PS-exposed apoptotic cells.
Fig. 5. (A) Sequence alignment of different C2domains. Sequence alignment ofmouseMFG-E8 C2domainwith homologous C2domainswasmade through the ESPriptWeb server.White
characters on a red background denote identical residues shared by all ﬁve sequences. Red characters on a white background indicate residues shared by two or more sequences. Δ in-
dicates residues at which point mutations are attempted for analyzing PS binding. The UniProtKB data base entries used in the sequence alignment are as follows: P21956 for mouse
MFG-E8 C2; Q95114 for bovine MFG-E8 C2; Q08431 for human MFG-E8 C2; P12259 for human factor V; P00451 for human factor VIII. (B) Binding orientation of serine-carboxyl head
group at the loops 2–3 region. Serine-carboxyl head group of PS interacts with Gln77 and Arg146 by salt bridge interactions while the phosphate group interacts with Lys45 and
Phe81 by hydrogen bonding. Lys45 also makes a hydrogen bond with the carbonyl moiety on ester acyl chains and the hydrophobic interactions with solvent exposed residues, such
as Trp26 and Phe81 with acyl side chains, stabilize the docking of PS with the C2 domain. (C) Electrostatic potential map of the C2 domain showing the inﬂuence of positive charges
in driving the docking of PS head group into the loop regions of the C2 domain. C2 is shown as surface representation whereas PS is shown in stick representation.
1089H. Ye et al. / Biochimica et Biophysica Acta 1828 (2013) 1083–10933.7. Hydrophobic residues in the binding loop of the C2 domain contribute to
the binding to PS-exposed apoptotic cells
From the computational modeling studies, we found several
hydrophobic residues in the binding loops of MFG-E8 C2 domain
and checked whether these residues were also involved in the bind-
ing between MFG-E8 and PS. Two aromatic residues, Trp26 and
Phe81, were substituted to alanine and then the binding of the C2
domain mutants for PS detected by ﬂow cytometry. The binding of
the C2 single mutants to apoptotic cells was relatively unchanged as
compared with that of the C2 wild type domain (Fig. 8A), with ap-
proximately 70% of cells not binding (gate M1) (Fig. 8B). However,the double mutant showed that more than 85% of cells in the M1
gate, suggesting that aromatic residues are also involved in the bind-
ing to PS-exposed apoptotic cells (Fig. 8).
4. Discussion
MFG-E8 is an important participant of the immuno-scavenging
process. It is secreted by activated macrophages in large quantities,
and functions as a linker between macrophages and their target apo-
ptotic cells, thus playing the role of an opsonin [28]. It was previously
shown that mutations in MFG-E8 gene could lead to dysfunction in
apoptotic cell clearance, causing in an autoimmune condition in mice
Fig. 6. Binding of C2 domain to PS on the outer membrane of apoptotic cells. (A) HeLa cells were treated with 100 μM etoposide for 24 h, incubated with annexin V (top panel) or
1 μM EGFP-tagged wild type C2 domain (bottom panel), both in the presence of PI, and then analyzed by ﬂow cytometry. Untreated cells were used as a control for both conditions.
Normal and apoptotic cells are shown in purple and green, respectively. The ﬂuorescence intensity gates (M1 and M2) are depicted in the each panel. (B) Percentage of cells treated
with etoposide in the right lower quadrant was calculated and compared with to control (untreated) cells. Increasing concentrations of the EGFP-tagged C2 domain were added to
the cells (x-axis). Results are mean±SE value from three experiments. A-V, annexin V positive control cells.
1090 H. Ye et al. / Biochimica et Biophysica Acta 1828 (2013) 1083–1093[3]. As MFG-E8 binds to apoptotic cells via the exposed PS through its C2
domain [6], we can propose that mutations in the PS binding site, which
cause a decrease in PS binding activity, might account for some of these
cases of autoimmunity. Our study has shown that there are critical resi-
dues in the C2 domain that, whenmutated, can decrease PS binding abil-
ity of the C2 domain, both in vitro and in vivo. Thus, together with our
solution structure of MFG-E8 C2 domain, we can make an assumption
as to themechanism of binding activity betweenMFG-E8 C2 and exposed
PS on apoptotic cells.The structure study has demonstrated that the surface of the
MFG-E8 C2 domain has a unique distribution of charged residues;
i.e., positively charged residues are positioned toward the PS binding
site. Therefore, this distribution of positively charged residues allows
the C2 domain to bind with the negatively charged head group of a
particular phospholipid, with high afﬁnity. As indicated by the 1H-15N
HSQC titrationwith 06:0 PS, and conﬁrmed by 31P-NMR and ﬂow cytom-
etry studies, mutation of critical positively charged residues, such as
lysine or arginine, to negatively charged residues, causes a dramatic
Fig. 7. Positively charged residues in C2 domain are involved in the binding to PS-exposed apoptotic cells. (A) HeLa cells were treated with 100 μM etoposide for 24 h, incubated
with 1 μM of EGFP-tagged C2 domain wild type, K24N, K45N, or K24N/K45N, and then analyzed by ﬂow cytometry. Normal and apoptotic cells are shown in purple and green,
respectively. The ﬂuorescence intensity gates (M1 and M2) are depicted in the each panel. (B) Percentage of cells treated with etoposide in the M1 gated region was calculated
as compared with each control. Results are mean±SE value from three experiments.
1091H. Ye et al. / Biochimica et Biophysica Acta 1828 (2013) 1083–1093decrease in PS binding ability, with binding almost completely abolished
with a double point mutation. Therefore, positively charged residues on
the PS binding sites are critical for the binding activity.In the MFG-E8 C2 domain, the loops are involved in the PS binding
activity. In addition to the positively charged residues that bind with
the negatively charged phospholipids, several hydrophobic residues
Fig. 8. Hydrophobic residues in the binding loop of C2 domain contribute to the binding to PS-exposed apoptotic cells. (A) HeLa cells were treated with 100 μM etoposide for 24 h,
incubated with annexin V or 1 μM EGFP-tagged C2 domain wild type, W26A, F81A, or W26/F81A, and then analyzed by ﬂow cytometry. Normal and apoptotic cells are shown in
purple and green, respectively. The ﬂuorescence intensity gates (M1 and M2) are depicted in the each panel. (B) Percentage of cells treated with etoposide in the M1 gated region
was calculated as compared with each control. Results are mean±SE value from three experiments.
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1093H. Ye et al. / Biochimica et Biophysica Acta 1828 (2013) 1083–1093are also found on the tip of the loops that are involved in binding. We
observed an almost 50% reduction in binding to PS from a double mu-
tation of Trp26 and Phe81 in the C2 domain, but no effect from the
single point mutants. This ﬁnding suggests a supportive role of
these aromatic residues in the binding activity.
As shown by previous results, membrane binding models for
discoidin C2 domain involve basic patch formed by lysine and arginine
side chains and aromatic and aliphatic side chains that are thought to
be inserted into themembrane [29]. Similarly in our study, the positively
charged residues bind strongly with the negatively charged head groups
on the surface of the phospholipids through electrostatic interactions,
and the relatively hydrophobic aromatic residues on the tip of the two
loops insert into the core of the phospholipids and stabilize the binding
with hydrophobic interactions. It is noteworthy that the F81A mutant
showed a signiﬁcant difference in PS binding as compared with the
W26A mutant (Pb0.05). Considering its deeper position in the binding
loop, we could gain some conﬁrmation for our hypothesis from this
experimental observation.
While MFG-E8 has its integrin binding site on the EGF domains on
the other side of the protein and its interaction is critical for the
phagocyte-mediated engulfment in response to apoptotic stimuli,
the functional role of PS binding via the C2 domain in the pathology
of autoimmunity awaits further studies. Future studies involving
patient samples might provide new insight into the biological role
of MFG-E8 in recognizing PS during apoptosis.
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